Casey Woodring
Stock Analyst at JP Morgan
(0.51)
# 4,101
Out of 5,008 analysts
35
Total ratings
23.81%
Success rate
-17.79%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Overweight | $60 → $70 | $63.44 | +10.34% | 1 | Sep 25, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $145 → $160 | $170.10 | -5.94% | 8 | Aug 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $186.65 | -19.64% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $27.71 | -9.76% | 4 | Apr 21, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $67.73 | +38.79% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $46.80 | +18.85% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.16 | +89.87% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $21.44 | +7.28% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $16.08 | +11.94% | 2 | Jan 23, 2023 |
Guardant Health
Sep 25, 2025
Maintains: Overweight
Price Target: $60 → $70
Current: $63.44
Upside: +10.34%
Charles River Laboratories International
Aug 7, 2025
Maintains: Neutral
Price Target: $145 → $160
Current: $170.10
Upside: -5.94%
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $186.65
Upside: -19.64%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $27.71
Upside: -9.76%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $67.73
Upside: +38.79%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $46.80
Upside: +18.85%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.16
Upside: +89.87%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $21.44
Upside: +7.28%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $16.08
Upside: +11.94%